摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

十六烷酸钾 | 2624-31-9

中文名称
十六烷酸钾
中文别名
棕榈酸钾;棕櫚酸鉀
英文名称
——
英文别名
——
十六烷酸钾化学式
CAS
2624-31-9
化学式
C16H32KO2
mdl
——
分子量
295.52
InChiKey
NHOGTCIENBDOGA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 闪点:
    12 °C

计算性质

  • 辛醇/水分配系数(LogP):
    5.17
  • 重原子数:
    19
  • 可旋转键数:
    14
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    F
  • 安全说明:
    S16,S7
  • 危险类别码:
    R11
  • RTECS号:
    ML9830000
  • 海关编码:
    2915709000
  • 危险品运输编号:
    UN 1219 3/PG 2

SDS

SDS:e3668537de4054b423d76ff90440e174
查看

制备方法与用途

用途

棕榈酸钾,又名软脂酸钾,学名为十六烷酸钾,是棕榈酸的钾盐,分子式为C16H31KO2。它主要用于制造棕榈酸钾皂,广泛应用于液体肥皂产品的生产中。

文献信息

  • [EN] STERICALLY HINDERED AMINE STABILIZERS<br/>[FR] STABILISANTS D'AMINES À ENCOMBREMENT STÉRIQUE
    申请人:BASF SE
    公开号:WO2010142572A1
    公开(公告)日:2010-12-16
    The instant invention pertains to hindered amine compounds having at least two nitrogen atoms with different basicity. One part is substituted on the N-atom by alkoxy moieties and the other part is substituted on the N-atom by a hydroxy-alkyl moiety. These materials are particularly effective in stabilizing polymers, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation. The compounds are also particularly effective in stabilizing acid catalyzed and ambient cured coatings systems.
    这项瞬时发明涉及具有至少两个氮原子且碱度不同的受阻胺化合物。其中一部分在N原子上被烷氧基团取代,另一部分在N原子上被一个羟基-烷基基团取代。这些材料在稳定聚合物方面特别有效,尤其是热塑性聚烯烃,可以抵御氧化、热和光辐射的有害影响。这些化合物在稳定酸催化和环境固化的涂层系统方面也特别有效。
  • LONG-ACTING RASAGILINE PRODRUG, PREPARATION METHOD AND USE THEREOF
    申请人:Guangzhou Henovcom Bioscience Co., Ltd
    公开号:EP3674289A1
    公开(公告)日:2020-07-01
    Provided are a long-acting prodrug of Rasagiline, preparation method and use thereof. The long-acting prodrug of Rasagiline has a structure of formula (I), wherein T is absent, or T is selected from (II); each of R1 and R2 is independently selected from H, D, and alkyl; W is absent, or W is selected from (CH2)n, wherein n is an integer selected from 1 to 15; X is absent, or X is selected from (CH2)m, wherein m is an integer selected from 1 to 10; Y is absent, or Y is selected from -C(=O)NH-, -NHC(=O)-; R3 is selected from substituted or unsubstituted C1-C30 alkyl, substituted or unsubstituted C2-C30 alkenyl, substituted or unsubstituted C2-C30 alkynyl, substituted or unsubstituted C3-C30 cycloalkyl, cholane aliphatic group, -R3a-C(=O)O-R3b, -R3a-OC(=O)-R3b, -R3a-C(=O)NH-R3b, -R3a-NHC(=O)-R3b, -R3a-S(=O)1-2O-R3b and -R3a-OS(=O)1-2-R3b. The provided prodrug of Rasagiline has a high melting point and low solubility, and it can form a drug reservoir in the body after being administered if it is made in a form of injection, prolonging the release rate of the prodrug in the body and achieving an effect of long-acting treatment.
    提供了拉沙吉林的长效前药、制备方法及其用途。拉沙吉林的长效前药具有如下结构式(I),其中T为空缺,或T选自(II);R1和R2中的每一个独立选自H、D和烷基;W为空缺,或W选自(CH2)n,其中n为1至15之间的整数;X为空缺,或X选自(CH2)m,其中m为1至10之间的整数;Y为空缺,或Y选自-C(=O)NH-、-NHC(=O)-;R3选自取代或未取代的C1-C30烷基、取代或未取代的C2-C30烯基、取代或未取代的C2-C30炔基、取代或未取代的C3-C30环烷基、胆烷脂肪基、-R3a-C(=O)O-R3b、-R3a-OC(=O)-R3b、-R3a-C(=O)NH-R3b、-R3a-NHC(=O)-R3b、-R3a-S(=O)1-2O-R3b和-R3a-OS(=O)1-2-R3b。所提供的拉沙吉林前药具有高熔点和低溶解度,如果以注射剂形式制备,则可在体内形成药物储库,延长前药在体内的释放速率,达到长效治疗的效果。
  • BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
    申请人:SENOMYX, INC.
    公开号:US20160376263A1
    公开(公告)日:2016-12-29
    The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
    本发明涵盖已知用于改变苦味感知的化合物和组合物,以及所述组合物和化合物与额外的组合物、化合物和产品的组合。示例组合物包括以下一种或多种:冷却剂;无活性药物成分;活性药用成分;食品添加剂或食品;调味剂或调味增强剂;食品或饮料产品;苦味化合物;甜味剂;苦味剂;酸味调味剂;咸味调味剂;鲜味调味剂;植物或动物产品;已知用于宠物护理产品中的化合物;已知用于个人护理产品中的化合物;已知用于家用产品中的化合物;制药制剂;局部制剂;大麻衍生或与大麻相关的产品;已知用于口腔护理产品中的化合物;饮料;香味、香水或除臭剂;已知用于消费品中的化合物;硅化合物;磨料;表面活性剂;发热剂;吸烟物品;脂肪、油脂或乳化剂;和/或益生菌或补充剂。
  • AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
    申请人:Kato Shiro
    公开号:US20100249399A1
    公开(公告)日:2010-09-30
    Disclosed is a compound having a strong affinity to serotonin-4 receptors, which is useful as an enterokinesis-promoting agent or a digestive tract function-improving agent. Specifically, disclosed is a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. Also specifically disclosed is a pharmaceutical composition containing a compound represented by Formula (1) or a pharmaceutically acceptable salt thereof. [In Formula (1), Ar represents a group represented by Formula (Ar-1) or Formula (Ar-2).]
    揭示了一种具有强烈亲和力的化合物,对5-羟色胺-4受体具有亲和力,可用作促进肠动力或改善消化道功能的药剂。具体地,揭示了一种由化学式(1)表示的化合物或其药学上可接受的盐。还具体揭示了一种含有由化学式(1)表示的化合物或其药学上可接受的盐的药物组合物。【在化学式(1)中,Ar代表由化学式(Ar-1)或化学式(Ar-2)表示的基团。】
  • Thioimidazolidine derivatives as light stabilizers for polymers
    申请人:——
    公开号:US20030109609A1
    公开(公告)日:2003-06-12
    A compound of the formula (I) wherein G 1 , G 2 , G 3 and G 4 are independently of one another C 1 -C 18 alkyl or C 5 -C 12 cycloalkyl or the radicals G 1 and G 2 and the radicals G 3 and G 4 form independently of one another, together with the carbon atom they are attached to, C 5 -C 12 cycloalkyl; R is hydrogen, C 1 -C 18 alkyl, oxyl, —OH, —CH 2 CN, C 3 -C 6 alkenyl, C 3 -C 8 alkynyl, C 7 -C 12 phenylalkyl unsubstituted or substituted on the phenyl radical by C 1 -C 4 alkyl and/or C 1 -C 4 alkoxy; C 1 -C 8 acyl, C 1 -C 18 alkoxy, C 1 -C 18 hydroxyalkoxy, C 2 -C 18 alkenyloxy, C 5 -C 12 cycloalkoxy, C 7 -C 12 phenylalkoxy unsubstituted or substituted on the phenyl radical by C 1 -C 4 alkyl and/or C 1 -C 4 alkoxy: C 1 -C 18 alkanoyloxy, (C 1 -C 18 alkoxy)carbonyl, glycidyl or a group —CH 2 CH(OH)(G) with G being hydrogen, methyl or phenyl; n is 1, 2, 3 or 4; and X is an organic radical of a valency equal to n; and when n is 2, 3 or 4, each of the radicals G 1 , G 2 , G 3 , G 4 and R can have the same or a different meaning in the units of the formula (II), is useful for stabilizing an organic material against degradation induced by light, heat or oxidation.
    式(I)的化合物,其中G1、G2、G3和G4彼此独立地是C1-C18烷基或C5-C12环烷基,或者基团G1和G2以及基团G3和G4彼此独立地与它们附着的碳原子一起形成C5-C12环烷基;R是氢、C1-C18烷基、氧基、—OH、—CH2CN、C3-C6烯基、C3-C8炔基、C7-C12苯基烷基,未取代或通过C1-C4烷基和/或C1-C4烷氧基取代苯基上的苯基基团;C1-C8酰基、C1-C18烷氧基、C1-C18羟基烷氧基、C2-C18烯氧基、C5-C12环烷氧基,未取代或通过C1-C4烷基和/或C1-C4烷氧基取代苯基上的C7-C12苯基氧基;C1-C18烷酰氧基、(C1-C18烷氧基)羰基、环氧乙基或一个基团—CH2CH(OH)(G),其中G是氢、甲基或苯基;n为1、2、3或4;X是价数等于n的有机基团;当n为2、3或4时,式(II)的各单元中的G1、G2、G3、G4和R的每一个可以具有相同或不同的含义,对于抵抗光、热或氧化引起的有机材料降解具有稳定作用。
查看更多